Pliant Therapeutics (PLRX) Other Non Operating Income (2019 - 2020)
Pliant Therapeutics' (PLRX) quarterly Other Non Operating Income came in at -$97000.0 in Q4 2020, up 42.26% year-over-year from -$68184.1 in Q1 2020, and down 276.36% quarter-over-quarter from $55000.0 in Q3 2020.
Powered by 
Analysis
Pliant Therapeutics (PLRX) Other Non Operating Income (2019 - 2020) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Other Non Operating Income for 2 consecutive years, with -$97000.0 the latest figure, recorded in Q4 2020.
- On a quarterly basis, Other Non Operating Income rose 42.26% year-over-year to -$97000.0 in Q4 2020; TTM through Dec 2020 was -$346000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$1.8 million, changed N/A from the prior year.
- Other Non Operating Income was -$97000.0 for Q4 2020 at Pliant Therapeutics, down from $55000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $55000.0 in Q3 2020 and troughed at -$168000.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Pliant Therapeutics | 71.21 Mn | 71.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -97,000.00 |
| Sep 30, 2020 | 55,000.00 |
| Jun 30, 2020 | -136,000.00 |
| Dec 31, 2019 | -168,000.00 |
| Sep 30, 2019 | -41,000.00 |
| Jun 30, 2019 | -21,000.00 |